Frazier Life Sciences Management, L.P. Mirum Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $2.36 Billion
- Q3 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 6,795,121 shares of MIRM stock, worth $485 Million. This represents 21.07% of its overall portfolio holdings.
Number of Shares
6,795,121
Previous 6,795,121
-0.0%
Holding current value
$485 Million
Previous $346 Million
44.06%
% of portfolio
21.07%
Previous 18.24%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
291Shares Held
57.5MCall Options Held
86.1KPut Options Held
105K-
Janus Henderson Group PLC London, X05MShares$357 Million0.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$231 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$182 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.52MShares$180 Million3.41% of portfolio
-
Bvf Inc San Francisco, CA1.5MShares$107 Million5.93% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...